Return to search

WCAS-backed Valtruis recruits Winokur as executive advisor

She is the former CEO of NeueHealth.

New York-based venture firm Valtruis, which is backed by Welsh, Carson, Anderson & Stowe, has named Rachel Winokur as executive advisor. She is the former CEO of NeueHealth.


NEW YORK–(BUSINESS WIRE)–Valtruis, a Welsh, Carson portfolio company, has recruited Rachel Winokur as an Executive Advisor. Winokur brings 25 years of experience in healthcare leadership roles, building strategy and significant revenue streams for payors, provider organizations, digital health companies, and medical device developers.

“We are delighted to welcome Rachel to our team,” said Anna Haghgooie, a Managing Director at Valtruis. “Rachel is a dynamic business leader and investor with years of experience in healthcare. She is also the kind of business professional and innovator we are eager to partner with – not simply for her many significant accomplishments, but for her passion to transform healthcare for all stakeholders.”

Among her many accomplishments, Winokur has started and scaled multiple businesses from zero to 1,000+ people, generating revenues of up to $4B. She served as the Chief Executive Officer of NeueHealth, Bright Health Group’s value-based care business, and helped start Bright Health in 2016 as its Chief Business Officer. Winokur has also worked as a senior executive for Aetna, helping to build the company’s population health management business, launching a dozen new businesses to serve both employer and provider customers, and managing a P&L of over $100M in revenue.

In addition to her operating roles, Winokur spent several years as a healthcare investor at The Carlyle Group and as an advisor to several venture capital and private equity funds. Winokur has played a key role in founding multiple businesses, forged nearly $1B in strategic partnerships, raised over $1B in capital for companies, and has sat on a number of corporate boards, including her current positions on the boards of Eating Recovery Center, Eleanor Health, and Maven. She holds an MBA from Stanford University’s Graduate School of Business and a Bachelor of Science in Engineering with honors in both biomedical and electrical engineering from Duke University, where she was awarded a fellowship through the National Science Foundation.

“I am honored and inspired to be joining Valtruis,” said Winokur. “I’m honored to join a company that has achieved so much in under a year, and I’m inspired by their mission to align and transform healthcare through true value-based care. The Valtruis team and I share the commitment to deliver measurable results for all stakeholders and I am looking forward to working with them to achieve this success.”

Winokur is the second Executive Advisor Valtruis has recruited in 2022, joining Dave Esler on the Valtruis Executive Advisor Team.

About Valtruis
Valtruis, a WCAS portfolio company, provides a unique platform that invests in and partners with disruptive leaders whose mission is to align and transform healthcare through what is truly value-based care. Founded on a commitment to accelerate meaningful change, Valtruis brings the functional expertise, access to capital and an expansive network that advance our partners’ evolution from early-stage development to industry-leading enterprises. Together, Valtruis and its partner companies will break through the systemic barriers in the healthcare industry to reduce costs, expand access, increase quality and radically improve the patient experience. Learn more at